Loss of mesodermal competence (LMC) during Xenopus development is a well known but little understood phenomenon that prospective ectodermal cells (animal caps) lose their competence for inductive signals, such as activin A, to induce mesodermal genes and tissues after the start of gastrulation. Notch signaling can delay the onset of LMC for activin A in animal caps [Coffman, C.R., Skoglund, P., Harris, W.A., Kintner, C.R., 1993. Expression of an extracellular deletion of Xotch diverts cell fate in Xenopus embryos. Cell 73, 659-671], although the mechanism by which this modulation occurs remains unknown. Here, we show that Notch signaling also delays the onset of LMC in whole embryos, as it did in animal caps. To better understand this effect and the mechanism of LMC itself, we investigated at which step of activin signal transduction pathway the Notch signaling act to affect the timing of the LMC. In our system, ALK4 (activin type I receptor) maintained the ability to phosphorylate the C-terminal region of smad2 upon activin A stimulus after the onset of LMC in both control-and Notch-activated animal caps. However, C-terminal-phosphorylated smad2 could bind to smad4 and accumulate in the nucleus only in Notchactivated animal caps. We conclude that LMC was induced because C-terminal-phosphorylated smad2 lost its ability to bind to smad4, and consequently could not accumulate in the nucleus. Notch signal activation restored the ability of C-terminal-phosphorylated smad2 to bind to smad4, resulting in a delay in the onset of LMC. q
Introduction
Mesoderm induction is a key event during early Xenopus development and is essential for correct body patterning. It takes place in the equatorial region by the signals from the vegetal hemisphere. Many studies in the past decade have focused on how mesodermal induction is initiated and a host of mesoderm-inducing signals have been identified. Mesodermal induction is a time-restricted phenomenon, in that at some point of development, receiving cells lose their competence for mesoderm-inducing signals and mesodermal induction is terminated; this is described as 'loss of mesodermal competence (LMC)'. Analysis of LMC has been carried out predominantly in prospective ectodermal cells (animal caps) using activin A, a member of the transforming growth factor-b (TGF-b) family, as a mesodermal inducer. Activin A has a strong mesoderm-inducing activity (Asashima et al., 1990 ) and can induce a broad range of mesodermal genes and tissues in animal caps from the morula through to the blastula stage. However, after the start of gastrulation, animal caps lose their competence for activin A (Grainger and Gurdon, 1989; Grimm and Gurdon, 2002; Steinbach et al., 1997) .
Smad proteins function as intracellular transducers for TGF-b family members. Smad proteins are classified into three groups. The first is the receptor-activated Smads (R-smads); of these smad2 and smad3 participate in activin and TGF-b signaling, whereas smad1, smad5, and smad8 participate in bone morphogenetic protein signaling. The second group is the common partner Smads (Co-smads), which comprises smad4. The final group is the inhibitory Smads (I-smads) comprising smad6 and smad7. Activin A regulates cellular processes by binding to a heteromeric complex of type I and type II serine/threonine kinase receptors. Upon Activin A binding, the activin type I receptor (ALK4) is phosphorylated and activated by the type II receptor. The activated ALK4 then phosphorylates smad2 at its C-terminal SSXS consensus motif. ALK4-mediated phosphorylation increases the affinity of smad2 for smad4 to form a heteromeric complex, which subsequently translocates to and accumulates in the nucleus where it participates in the transcriptional activation of specific genes in collaboration with DNAbinding cofactors.
A previous study showed that activation of Notch signaling enables activin A to induce muscle actin expression even after the start of gastrulation, suggesting that Notch signaling can delay the onset of LMC in animal caps (Coffman et al., 1993) . Notch signaling is important for multipotent precursor cells to achieve a specific cell fate during the development of numerous tissues. Notch encodes a large transmembrane protein that serves as a receptor for the Delta, Serrate and Lag-2 (DSL) family of ligands. Binding of a DSL ligand to the extracellular domain of Notch causes cleavage of the intracellular domain (De Strooper et al., 1999; Mumm et al., 2000) . The intracellular domain of Notch is released from the membrane and translocates into the nucleus, where it can interact with members of the CBF-1, Suppressor of Hairless, Lag-1 (CSL) family. This interaction converts the CSL proteins from transcriptional repressors into transcriptional activators (Kao et al., 1998; Zhou et al., 2000a,b) . The complex of DSL and the intracellular domain of Notch subsequently activates the expression of target genes, such as ESR, Hairy and Hey (Bailey and Posakony, 1995; Lecourtois and Schweisguth, 1995; Leimeister et al., 1999; Tannahill et al., 1995) .
During early development, LMC is an essential phenomenon. If LMC did not occur at the proper time, receiving cells would over-respond to inductive signals and tissues would become too large or inappropriate. However, the mechanism of LMC and how Notch signaling modulates the timing of the LMC remains unknown. Our results now show that Notch signaling modulates the onset of LMC in whole embryos, as it does in animal caps. Furthermore, we demonstrate that LMC occurs when C-terminal-phosphorylated smad2 can no longer bind to smad4 and consequently could not accumulate in the nucleus. Notch activation enables C-terminal-phosphorylated smad2 to still form a complex with smad4 and accumulate in the nucleus even after the start of gastrulation.
Results

Notch signaling delayed the onset of loss of mesodermal competence
A previous study showed that activin A could induce muscle actin expression even after the start of gastrulation in Notch-activated animal caps (Coffman et al., 1993) . The authors reasoned that Notch signaling had two effects on activin signaling: an extension of the period during which animal caps respond to activin A, and enhancement of the sensitivity of animal caps for activin A leading to enhanced mesoderm induction.
To confirm the effect of Notch signaling on activin signaling in our system, precise levels of expression of the activin A-inducible pan-mesodermal gene, Xbra, and the organizer-specific mesodermal gene, goosecoid, were compared between Notch-activated animal caps and control animal caps using real-time RT-PCR. Notch DE, which contains an extracellular deletion, functions as a constitutively active form of Notch (Onuma et al., 2002) . Notch DE-injected or control animal caps were dissected from stage-9, -10.5, and -11.5 embryos and treated with activin A. In all of the stages examined, Xbra (Fig. 1A) and goosecoid (Fig. 1B) were not expressed in the absence of activin A treatment in any of the embryos, regardless of whether Notch DE was injected. This result indicated that Notch signaling alone does not induce Xbra and goosecoid expression. The expression levels of Xbra and goosecoid in Notch DE-injected stage-9 animal caps treated with activin A were the same as those in control animal caps at the same stage (Xbra; 1.1-fold, goosecoid; 1.2-fold), which indicated that Notch signaling did not enhance mesoderm induction at stage-9, which is prior to the onset of LMC. However, when stage-10.5 and -11.5 animal caps were treated with activin A, Xbra and goosecoid expression levels in the Notch DE-injected animal caps were higher than those in control animal caps (Xbra, 2.4-fold at stage 10.5 and 10.8-fold at stage 11.5; goosecoid, 3.6-fold at stage 10.5 and 2.6-fold at stage 11.5). Previous reports indicated that both Su(H)-dependent and -independent Notch pathways are involved in early development (Martinez Arias et al., 2002; Nofziger et al., 1999) . To confirm which of these pathways modulates activin Ainduced mesodermal gene expression, Su(H) DBM, a dominant-negative DNA-binding mutant of Su(H), was coinjected with Notch DE. The level of expression of Xbra in the activin A-treated stage-11.5 animal caps decreased to a level equivalent to that of control animal caps, indicating that Su(H) DBM efficiently inhibited the effect of Notch DE (Fig. 1C) . These results indicated that Notch signaling did not enhance the sensitivity of ectodermal cells to activin A, but rather, seemed to delay the onset of LMC through a Su(H)-dependent pathway.
Loss of mesodermal competence in vivo
Our results in Fig. 1 support previous studies showing that LMC for activin A takes place in animal caps (Grainger and Gurdon, 1989; Grimm and Gurdon, 2002; Steinbach et al., 1997) . Next we asked whether LMC for activin A also occurs in vivo, and whether Notch signaling modulates the timing of the LMC, as seen with the animal caps. To address this, we implanted an activin bead (Gurdon et al., 1994 (Gurdon et al., , 1995 into the ventral margin of blastocoels ( Fig. 2A) . Implantation of the activin bead into stage-9 embryos led to formation of secondary trunk-tail structures ( Fig. 2B and Table 1 ). In stage-11.5 embryos, the activin bead caused secondary structures as well, but much smaller protrusions, which suggests that stage-11.5 embryos had started to lose competence for activin A (Fig. 2C) . However, when Notch DE was injected into a single ventral blastomere at the 4-cell stage, activin beadimplanted embryos formed exact secondary trunk-tail structures similar to stage-9 embryos, indicating that Notch DE-injected embryos could respond to activin A even at stage 11 (Fig. 2D) . Implantation of an activin bead led to the formation of very small protrusions in stage-12 Notch DE-injected embryos (Fig. 2F red arrowhead) , but not in stage-12 control embryos (Fig. 2E) . Control bead implantation into control embryos (Fig. 2G ) or into Notch DE-injected embryos (data not shown), and the injection of Notch DE alone never induced formation of any secondary structures (Fig. 2H ). Histological analysis showed that the secondary trunk-tail structures were apparently different from the yolk-rich endodermal tissue (Fig. 2I,H) . To examine which tissues formed the secondary trunk-tail structures, sections were stained with the muscle-specific 12/101 antibody (Kintner and Brockes, 1985) (Fig. 2K) , neuron-specific Neu-1 antibody (Itoh and Kubota, 1989) (Fig. 2L ), or notochord-specific Tor 70 antibody (Bolce et al., 1992) (Fig. 2M ). The secondary trunk-tail structures contained muscle and neural tissues, but no notochord.
We further examined the influence of Notch signaling on endogenous Xbra expression. Xbra is expressed in involuting mesodermal cells when gastrulation starts. During gastrulation, Xbra expression is downregulated in involuting mesoderm, while expression is maintained in the prospective notochord (Smith et al., 1991) . Xbra expression in involuting mesoderm is induced by activin-like signaling (Agius et al., 2000; Chang et al., 1997) . Notochordal Xbra expression was reduced by injection of Notch DE (Fig. 2O , blue arrowhead, 65% nZ74), in agreement with a previously study (Lopez et al., 2003) . In contrast, the region of Xbra expression in involuting mesoderm was enlarged in the Notch-DE injected embryos (Fig. 2O , red arrow, 53% nZ74), indicating that Notch signaling extended the period of competence for activin-like signaling, and the expression of Xbra seen in involuting mesoderm was maintained after gastrulation. Together, these results reveal that LMC for Fig. 1 . The effect of Notch signaling on activin-induced Xbra and goosecoid expression. Animal caps injected with 1 ng of Notch DE were dissected at stage 9, 10.5, and 11.5, and then treated with 10 ng/ml of activin A, followed by incubation for 5 h. The relative Xbra (A) and goosecoid (B) expression levels were calculated using real-time RT-PCR. (C) Animal caps injected with 1 ng Notch DE alone or co-injected with 1 ng Notch DE and 1 ng Su(H) DBM were dissected at stage 11.5, and then treated with 10 ng/ml activin A, followed by a 5-h incubation. The relative Xbra expression level was calculated using real-time RT-PCR. The efficiency of cDNA synthesis was assessed on the basis of real-time RT-PCR for ODC. The results represent the mean from three or four independent experiments and error bars indicate the SEM. Black column, Notch DE-injected animal caps; White column, uninjected control animal caps, Gray column, Notch DE and Su(H) DBM-injected animal caps.
activin A occurs in both animal caps and in vivo, and that the onset time of LMC was mediated by Notch signaling.
Notch signaling did not enhance the expression of ALK4
The mechanisms of LMC itself and how Notch signaling modulates the timing of the LMC remain to be elucidated. To address these questions, we examined the relationship between activin signaling and Notch signaling, and in particular the step of activin signal transduction pathway at which Notch signaling acts to modulate the period of competence for activin A.
First, we examined the expression levels of ALK4 in animal caps at stages 9, 10.5, and 11.5 using real-time RT-PCR (Fig. 3A) . In both control and Notch DE-injected animal caps, the expression level of ALK4 gradually decreased as development proceeded. In addition, the expression levels of ALK4 in Notch DE-injected animal caps were almost similar to those in control animal caps at all stages examined. We therefore concluded that the reduction in expression of activin receptor might not be due to the delayed onset of LMC caused by Notch signaling.
The C-terminal region of smad2 can be phosphorylated even after the onset of LMC
Upon activin A binding to its receptors, the type I receptor, ALK4 phosphorylates the C-terminal region of smad2. This phosphorylation is a key step in the activinlike signaling pathway and can be considered as an indicator of activin-like signal activation (Faure et al., 2000; Lee et al., 2001) . We examined whether activininduced phosphorylation of the C-terminal region of smad2 was influenced by Notch signaling. Notch DE-injected and control animal caps dissected from stage-9 and stage-11 embryos were treated with activin A, and the levels of Cterminal-phosphorylated smad2 were measured by western blotting using anti-phosphorylated-smad2C antibody (apsmad2C), which recognizes smad2 that is specifically phosphorylated in the C-terminal region (Fig. 3B) . Without activin treatment, C-terminal-phosphorylation of smad2 was barely detectable in both Notch DE-injected and control animal caps at stages 9 and 11. At stage 9, activin treatment induced C-terminal-phosphorylation of smad2 in the control animal caps to the same level as in Notch DEinjected animal caps. Surprisingly, even in stage-11 animal caps, smad2 could be phosphorylated at the C-terminal region upon activin A stimulus in both Notch DE-injected and control animal caps. These results indicate that ALK4 maintains the ability to phosphorylate at the C-terminal region of smad2 upon ligand binding, even after the onset of LMC, and that Notch signaling does not influence the phosphorylation level of the smad2 C-terminal region.
2.5. After the onset of LMC, smad2 loses it ability to bind to smad4, and cannot accumulate in the nucleus ALK4-mediated phosphorylation of the C-terminal region of smad2 increases the affinity of smad2 for smad4, resulting in a heteromeric complex. This complex then accumulates in the nucleus where it participates in the transcriptional activation of specific genes. We investigated whether Notch signaling had an effect on the complex formation between C-terminal-phosphorylated smad2 and smad4. Lysates of Notch DE-injected or control animal caps dissected from stage-9 and stage-11 embryos that were treated with activin A were immunoprecipitated using an anti-smad4 antibody. C-terminal phosphorylated smad2 in the immunoprecipitate was detected by western blotting using ap-smad2C (Fig. 4A,B) . In the absence of activin A treatment, the C-terminal region of Smad2 was not phosphorylated and there was virtually no interaction between smad2 and smad4 (Fig. 4, lane 1) . When stage-9 animal caps were treated with activin A, C-terminalphosphorylated smad2 formed a complex with smad4 in both control (Fig. 4, lane 2 top panel) and Notch DE-injected animal caps (Fig. 4, lane 3 top panel) . In stage-11 animal caps, activin A treatment induced phosphorylation of the smad2 C-terminal region in both control and Notch DE-injected animal caps (Fig. 4, lanes 4 and 5, bottom panel), however, C-terminal-phosphorylated smad2 bound to smad4 only in Notch DE-injected animal caps (Fig. 4, lane 5 top panel) , but not in control animal caps (Fig. 4, lane 4 top panel) .
Finally, we determined the effect of Notch signaling on the nuclear accumulation of smad2 using GFP-smad2 (Bourillot et al., 2002; Grimm and Gurdon, 2002) . In stage-9 animal caps without activin treatment, smad2 localized to the cytoplasm in both Notch DE-injected and control animal caps. When stage-9 animal caps were treated with activin A, smad2 localized to the nucleus in both Notch DE-injected and control animal caps (Fig. 5A) . However, when stage-11 animal caps were treated with activin A, nuclear localization The amount of C-terminal-phosphorylated smad2 was examined by western blotting using anti-phosphorylated-smad2C antibody (ap-smad2C), which recognized the phosphorylated C-terminal region of smad2. Animal caps injected with 1 ng of Notch DE or non-injected controls were dissected at stage 9 and stage 11, and treated with 50 ng/ml of activin A. Actin levels served as the loading control.
of smad2 was observed only in Notch DE-injected animal caps, and not in control animal caps (Fig. 5B) .
These results indicate that the LMC was induced when C-phosphorylated smad2 lost its ability to bind to smad4, and consequently could not accumulate in the nucleus after gastrulation. Notch signal activation maintained formation of the complex between C-terminal-phosphorylated smad2 and smad4, and subsequent nuclear accumulation of C-terminal-phosphorylated smad2, even after the onset of LMC.
Notch signal activation did not enhance linker-regionphosphorylation of smad2
A previous study suggested that phosphorylation of the linker region of smad2 may restrict the time of onset of mesodermal competence (Grimm and Gurdon, 2002) . We examined the effect of Notch signaling on phosphorylation of smad2 linker region using ap-smad2L antibody which is directed against a peptide that corresponds to the phosphorylated linker region of human smad2 (Mori et al., 2004) . To confirm that ap-smad2L cross-reacted with Xenopus smad2, Xenopus embryos were injected with mRNA encoding Xenopus GFP-smad2 or a mutated Xenopus GFP-smad2 (GFP-smad2-L3SA) in which the three linker region serine residues were substituted with alanine residues (Fig. 6A) . The phosphorylation signal observed with GFP-smad2 was abolished with GFPsmad2-L3SA, indicating that ap-smad2L cross-reacts with Xenopus and specially detects smad2 phosphorylated at the linker region (Fig. 6B) . Notch DE-injected and control animal caps were dissected from stage-11 embryos, Fig. 4 . The effect of Notch signaling on formation of a complex formation between C-terminal-phosphorylated smad2 and smad4. Animal caps injected with 1 ng of Notch DE (lanes 3 and 5) or control animal caps (lanes 1, 2 and 4) were dissected at stage 9 (lanes 1, 2 and 3) or stage 11 (lanes 4 and 5), and treated with 50 ng/ml of activin A. Lysates were immunoprecipitated with anti-smad4 antibody (IP) and western blotted with ap-smad2C antibody. The level of smad2 C-terminal phosphorylation was quantitated and the values plotted. Fig. 5 . The effect of Notch signaling on smad2 nuclear accumulation. Animal caps were injected with 500 pg of GFP-smad2 alone or co-injected with 500 pg of GFP-smad2 and 1 ng of Notch DE, and dissected at stage 9 (A) or stage 11 (B), and then dissociated in dissociation medium. Dissociated animal cap cells were treated with 5 ng/ml activin A for 30 min and then loaded onto a fibronectin-coated slide. The localization of GFP-smad2 was analyzed by confocal microscopy. and the levels of linker-region-phosphorylation were measured by western blotting using ap-smad2L. Notch signal activation had no apparent effect on the level of phosphorylation of smad2 liker region in stage 11 animal caps (Fig. 6C ).
Discussion
Notch signaling modulates mesodermal competence
A previous study showed that Notch signaling can delay the onset of LMC in animal caps (Coffman et al., 1993) . We therefore explored the mechanism of LMC by examining the relationship between Notch signaling and activin signaling, and how Notch signaling can modulate the LMC timing. Recent reports have demonstrated crosstalk between the Notch and TGF-b/activin signaling pathways, and between Notch and BMP signaling (de Jong et al., 2004; Zavadil et al., 2004) . We previously reported that activin A activates Notch signaling during mesodermal induction (Abe et al., 2004) . The intracellular domain of Notch cooperates with smad1 Itoh et al., 2004; Takizawa et al., 2003) or smad3 to regulate target gene expression and organogenesis.
We analyzed expression of the early mesodermal genes, Xbra and goosecoid in Notch DE-injected animal caps. Our real-time RT-PCR analysis revealed that Notch signal activation did not enhance the levels of activin A-induced Xbra or goosecoid expression in stage-9 animal caps. However, in stage-10.5 and -11.5 animal caps, Notch activation caused an increase in the expression of these genes. From these results, we concluded that Notch signaling could delay the onset of LMC for activin A, but could not change the sensitivity of animal caps to activin A and could not enhance mesoderm induction prior to the onset of LMC. Western blotting showed that Notch activation did not increase the levels of activin-induced phosphorylation of the smad2 C-terminal region, which further supported our idea. Our conclusions therefore agree with Coffman et al. (1993) . Whereas, these authors examined the relationship between Notch signaling and activin signaling from stage-10 animal caps onward, when LMC has already started, we traced precisely the activin Ainduced mesodermal gene expression levels before and after the onset of LMC, so as to distinguish between sensitivity and time of competence of animal caps.
We next wanted to investigate LMC in vivo. As the study of LMC in normal development is notoriously difficult, we assessed an artificially-induced in vivo LMC using an activin bead implantation method. This method allowed us to control the activation of activin signaling both temporally and spatially. In this system, the activin bead was able to induce larger secondary trunk-tail structures in Notch DE-injected stage-11 embryos than in control stage-11 embryos. Moreover, the activin bead could induce small protrusions in Notch DE-injected stage-12 embryos, but not in control stage-12 embryos. These secondary trunk-tail structures consisted of mesodermal tissues, and were postulated to mimic mesodermal induction in normal development. From these findings, we concluded that LMC for activin A took place in vivo as reported in animal caps, and that the timing of the LMC was modulated by Notch signaling. Furthermore, the increased area of Xbra expression region seen in involuting mesoderm in Notchactivated embryos suggested that Notch signaling can elongate the period of competence for activin-like signaling in normal development. In contrast to Xbra expression in involuting mesoderm, Notch signal activation repressed the notochordal Xbra expression (Fig. 2) (Lopez et al., 2003) . The regulatory sequences required for the expression of Xbra in involuting mesoderm are distinct from those required for the notochordal Xbra expression (Lerchner et al., 2000) . Therefore, the regulatory mechanisms of Xbra expression may differ between involuting mesoderm and notochord, and Notch signaling may have an opposite effect on Xbra expressions in these two sites. Notch signal activation did not increase expression region of goosecoid and XMyoD in vivo (data not shown). We do not know at present why Notch signal activation did not enhance MyoD expression in vivo, although Notch signal activation can induce muscle hyperplasia (Coffman et al., 1990) . The effect of Notch signaling on the period of competence may be difficult to detect because goosecoid and MyoD expression was maintained or increased during gastrulation, unlike Xbra expression in involuting mesoderm which was downregulated during gastrulation. smad2 and GFP-smad2-L3SA in which the three linker region serine residues were substituted by alanine residues. ap-smad2L selectively recognized smad2 phosphorylation at the linker region. (B) Two-cell-stage embryos were injected with GFP-smad2 or GFP-smad2-L3SA. Embryos were harvested at stage 12 and smad2 linkerregion phosphorylation levels were examined by western blotting using ap-smad2L. (C) Animal caps injected with 1 ng of Notch DE or noninjected controls were dissected at stage 11, and smad2 linker-region phosphorylation levels were examined by western blotting using ap-smad2L. Smad2 levels served as the loading control.
How does Notch signaling modulate LMC?
We wanted to investigate the mechanism underlying the onset of LMC. However, both activin and Notch signaling take part in a broad range of developmental steps, and their functions are not restricted to mesodermal induction. Furthermore, embryos consist of mixtures of several different cell populations, i.e. LMC may take place in some parts of the embryo, but not in other parts. Therefore, a mechanistic analysis of LMC using whole embryos is difficult and complicated. For these reasons, we took advantage of the animal cap system, which is regarded as a uniform population of undifferentiated, prospective ectodermal cells, and is widely used as an in vitro induction system mimicking induction events occurring in vivo. To our surprise, after the onset of LMC, C-terminal region of smad2 could still be phosphorylated upon activin A stimulus. However, this C-terminal-phosphorylated smad2 was no longer able to form a complex with smad4 and consequently could not accumulate in the nucleus. Notch signal activation reinstated the ability of C-terminalphosphorylated smad2 to bind to smad4 and to accumulate in the nucleus at stage 11, without changing the level of phosphorylation of the smad2 C-terminal region. C-terminal phosphorylation is not absolutely necessary for nuclear import of smad2, and in the unstimulated state, smad2 is constantly shuttled between the nucleus and cytoplasm (Xu et al., 2002) . C-terminal-phosphorylation of smad2 leads to its retention in the nucleus by virtue of phosphorylation-dependent association with smad4 and other additional components of the transcriptional complex. LMC may therefore be initiated because C-terminalphosphorylated smad2 can no longer form a complex with smad4 and other components, cannot be retained in the nucleus, and therefore cannot participate in downstream transcription events. Because accumulation of C-terminalphosphorylated smad2 in the nucleus is an essential and common event in all activin-like signaling pathways, we suggest that Notch signaling may have a general effect on activin A-induced gene expression.
We further speculated that the inhibition of Notch signaling might result in the early onset of LMC. However, Su(H) DBM, which antagonizes Notch signaling, did not inhibit the nuclear accumulation of C-terminal-phosphorylated smad2 in stage-9 animal caps (data not shown). In addition, injection of Su(H) DBM did not inhibit activin A-induced gene expression in stage-9 animal caps (data not shown). We showed that Su(H) DBM did diminish the effect of Notch DE on activin A-induced Xbra expression, meaning that Notch signaling delays the onset of LMC through a Su(H)-dependent pathway. It is possible that other signaling pathways were able to compensate for the lack of Su(H) activity.
Previous studies have demonstrated that the accumulation of somatic H1 linker histone causes LMC (Steinbach et al., 1997) , and phosphorylation of the smad2 linker region may restrict the time of mesodermal competence (Grimm and Gurdon, 2002) . Notch signal activation did not have any effect on the level of phosphorylation of the liker region of smad2 after the onset of LMC. Therefore, linker-region-phosphorylation of smad2 and Notch signaling may independently control the timimg of LMC. It is feasible that Notch signaling may regulate the accumulation of somatic H1 linker histone.
In conclusion, our results indicated that Notch signaling modulates the time of LMC both in animal caps and in vivo. LMC takes place because C-terminal-phosphorylated smad2 loses its ability to bind to smad4 and consequently cannot to accumulate in the nucleus, and Notch signaling modulates the nuclear localization of C-terminal-phosphorylated smad2, resulting in a change in the timing of LMC. Important questions that now need to be addressed include which mechanism is used by Notch signaling to induce the nuclear retention of the C-terminal-phosphorylated smad2/smad4 complex, even after gastrulation, and what effect Notch signaling has on mesodermal induction in normal development.
Experimental procedures
Embryo manipulation
Embryos were collected from Xenopus laevis females and artificially fertilized as previously described (Chan et al., 2000) . The staging of embryos was according to the method of Nieuwkoop and Faber (1956) . Embryos were injected with mRNA in a volume of 10 nl at the two-or four-cell stage. Animal caps were dissected in Steinberg's solution (pH 7.4) and treated with 50 ng/ml Activin A.
In vitro transcription
Recombinant plasmids of pCS2-Notch DE (Onuma et al., 2002) and GFP-smad2 (Bourillot et al., 2002) were used as templates for the capped mRNAs. The capped mRNAs were synthesized in vitro using the mMESSAGE mMACHINE T7 and SP6 kit according to the manufacturer's instructions (Ambion, Austin, TX). Digoxigenin-labeled antisense RNA probes were in vitro-transcribed with T7 polymerase from template cDNA for Xbra (Smith et al., 1991) using an RNA labeling kit (Roche Molecular Biochemicals).
Real-time RT-PCR
Real-time RT-PCR was performed on an ABI PRISM 7700 (Applied Biosystems) using SYBR Green PCR Master Mix (QIAGEN) as previously described (Abe et al., 2004) . The following primers were used (FZforward, RZ reverse): Xbra (F: 5 0 -TCTCTTTCACATGCTGTGCC-3 0 R:
GCTCCACAACA-3 0 ), ALK4 (F: 5 0 -ACAAGCAGGAACC-CAATGTCA-3 0 R: 5 0 -GCCAGAGCTGATTGTTTGGAG-3 0 ) and ODC (F: 5 0 -CAGCTAGC TGTGGTGTGG-3 0 R: 5 0 -CAACATGGAAACTCACACC-3 0 ).
Activin bead
Affigel blue beads (Bio-Rad) were washed three times in Steinberg's solution (pH 7.4), and then incubated in a solution of 50 ng/ml activin A containing 0.1% BSA for 40 min at 37 8C.
Histological and immunohistochemical examination
Embryos were fixed with MEMFA (0.1 M MOPS (pH 7.4), 2 mM EGTA, 1 mM MgSO 4 , 3.7% formaldehyde) at room temperature for 2 h, and then processed into paraffin for serial sectioning at 6-mm thickness. For histological examination, the sections were stained with hematoxylin and eosin. For immunohistochemical examination, the sections were immunostained with 12/101 (muscle-specific antibody) (Kintner and Brockes, 1985) , Neu-1 (neuron-specific antibody) (Itoh and Kubota, 1989) and Tor 70 (notochord-specific antibody) (Bolce et al., 1992) , and visualized with peroxidaseconjugated Simple Stain MAP PO goat anti-mouse IgG (Nichirei) 3-amino-9-ethylcarbazol (AEC, Nichirei).
In situ hybridization
Whole mount in situ hybridizations were performed according to Harland (1991) with an automatic in situ detection machine (InsituPro, ABIMED), except that the chromogenic reaction was done using BM purple (Roche Molecular Biochemicals) as substrate and the RNase treatment was omitted.
Immunoprecipitation and western blotting assay
Animal caps dissected from 50 embryos were homogenized in 30 ml of lysis buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA, and 1% TritonX-100) containing a protease inhibitor (Complete w , Roche). Immunoprecipitation was performed by incubation with anti-smad4 monoclonal antibody (Clone SMD46, Lab Vision Corporation) followed by adsorption to protein G-sepharose. Proteins were separated on 5-20% gradient gels by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to nitrocellulose membranes. The membrane was immunostained with anti-phospho-smad2C antibody (Cell Signaling Technology), anti-phospho-smad2L, anti-smad4 antibody, or anti-actin antibody (clone AC40, Sigma), followed by horseradish peroxidase-conjugated goat antirabbit IgG for phospho-smad2 or goat anti-mouse IgG for smad4 and actin. Bound antibodies were visualized using chemiluminescence (Supersignal West Femto Maximum Sensitivity substrate w , PIERCE Biotechnology).
Detection of GFP-Smad2 localization
Animal caps from embryos injected with 500 pg of GFP-smad2 mRNA were dissected at stage 9 or 11 and transferred into Ca 2C /Mg 2C -free Steinberg's solution containing 0.1% BSA (dissociation medium). Animal cap cells were dispersed by gentle pipetting and treated with 10 ng/ml activin A for 30 min, and then loaded on plastic slide coated with fibronectin (Sigma) at 16 mg/ml. We analyzed cells by confocal microscopy (Zeiss LSM510).
